Best practice for the management of pediatric thyroid cancer

References

• Holmes L Jr, Hossain J, Opara F. Pediatric thyroid carcinoma incidence and temporal trends in the USA (1973-2007): race or shifting diagnostic paradigm? ISRN Oncol 2012;2012:906197
   PubMedGoogle Scholar
• Farahati J, Bucsky P, Parlowsky T, et al. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 1997;80:2156-62
   PubMedGoogle Scholar
• Zivaljevic V, Tausanovic K, Sipetic S, et al. A case-control study of papillary thyroid cancer in children and adolescents. Eur J Cancer Prev 2013;22:561-5
   PubMedGoogle Scholar
• Shimizu Y, Kato H, Schull WJ, Hoel DG. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiat Res 1992;130:249-66
   PubMed Web of Science ®Google Scholar
• Borson-Chazot F, Causeret S, Lifante JC, et al. Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer. World J Surg 2004;28:1088-92
   PubMed Web of Science ®Google Scholar
• Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer 2006;13:427-53
   PubMedGoogle Scholar
• Park S, Jeong JS, Ryu HR, et al. Differentiated thyroid carcinoma of children and adolescents: 27-year experience in the yonsei university health system. J Korean Med Sci 2013;28:693-9
   PubMedGoogle Scholar
• Demidchik YE, Demidchik EP, Reiners C, et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 2006;243:525-32
   PubMedGoogle Scholar
• Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 2002;38:1-10
   PubMedGoogle Scholar
• Available from: www.cancer.gov/cancertopics/types/thyroid
   Google Scholar
• Hogan AR, Zhuge Y, Perez EA, et al. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res 2009;156:167-72
   PubMedGoogle Scholar
• Zimmerman D, Hay ID, Gough IR, et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 1988;104:1157-66
   PubMed Web of Science ®Google Scholar
• Welch Dinauer CA, Tuttle RM, Robie DK, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 1998;49:619-28
   PubMed Web of Science ®Google Scholar
• Shayota BJ, Pawar SC, Chamberlain RS. MeSS: a novel prognostic scale specific for pediatric well-differentiated thyroid cancer: a population-based, SEER outcomes study. Surgery 2013;154:429-35
   PubMedGoogle Scholar
• Zimmerman D. Thyroid carcinoma in children and adolescents: diagnostic implications of analysis of the tumor genome. Curr Opin Pediatr 2013;25:528-31
   PubMedGoogle Scholar
• Rivkees SA, Mazzaferri EL, Verburg FA, et al. The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr Rev 2011;32:798-826
   PubMed Web of Science ®Google Scholar
• Smith JR, Marqusee E, Webb S, et al. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome. J Clin Endocrinol Metab 2011;96:34-7
   PubMedGoogle Scholar
• Steinhagen E, Guillem JG, Chang G, et al. The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized. Clin Colorectal Cancer 2012;11:304-8
   PubMedGoogle Scholar
• Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the “complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas” (Carney complex). Ann NY Acad Sci 2002;968:3-21
   PubMed Web of Science ®Google Scholar
• Nose V. Thyroid cancer of follicular cell origin in inherited tumor syndromes. Adv Anat Pathol 2010;17:428-36
   PubMedGoogle Scholar
• Leeman-Neill RJ, Brenner AV, Little MP, et al. RET/PTC and PAX8/PPARgamma chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer 2013;119:1792-9
   PubMed Web of Science ®Google Scholar
• Yamashita S, Saenko V. Mechanisms of Disease: molecular genetics of childhood thyroid cancers. Nat Clin Pract Endocrinol Metab 2007;3:422-9
   PubMedGoogle Scholar
• Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214
   PubMed Web of Science ®Google Scholar
• Mussa A, Salerno MC, Bona G, et al. Serum thyrotropin concentration in children with isolated thyroid nodules. J Pediatr 2013;163(5):1465-70
   PubMedGoogle Scholar
• Gupta A, Ly S, Castroneves LA, et al. A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults. J Clin Endocrinol Metab 2013;98:3238-45
   PubMedGoogle Scholar
• Goldfarb M, Gondek SS, Sanchez Y, Lew JI. Clinic-based ultrasound can predict malignancy in pediatric thyroid nodules. Thyroid 2012;22:827-31
   PubMedGoogle Scholar
• Lyshchik A, Drozd V, Demidchik Y, Reiners C. Diagnosis of thyroid cancer in children: value of gray-scale and power doppler US. Radiology 2005;235:604-13
   PubMedGoogle Scholar
• Stevens C, Lee JK, Sadatsafavi M, Blair GK. Pediatric thyroid fine-needle aspiration cytology: a meta-analysis. J Pediatr Surg 2009;44:2184-91
   PubMedGoogle Scholar
• Smith M, Pantanowitz L, Khalbuss WE, et al. Indeterminate pediatric thyroid fine needle aspirations: a study of 68 cases. Acta Cytol 2013;57:341-8
   PubMedGoogle Scholar
• Redlich A, Boxberger N, Kurt Werner S, et al. Sensitivity of fine-needle biopsy in detecting pediatric differentiated thyroid carcinoma. Pediatr Blood Cancer 2012;59:233-7
   PubMedGoogle Scholar
• Cibas ES, Ali SZ. The bethesda system for reporting thyroid cytopathology. Thyroid 2009;19:1159-65
   PubMed Web of Science ®Google Scholar
• Penko K, Livezey J, Fenton C, et al. BRAF mutations are uncommon in papillary thyroid cancer of young patients. Thyroid 2005;15:320-5
   PubMedGoogle Scholar
• Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 2012;367:705-15
   PubMed Web of Science ®Google Scholar
• Gutnick J, Soldes O, Gupta M, Milas M. Circulating thyrotropin receptor messenger RNA for evaluation of thyroid nodules and surveillance of thyroid cancer in children. J Pediatr Surg 2012;47:171-6
   PubMedGoogle Scholar
• Gonzalez HE, Cruz F, O'Brien A, et al. Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2007;133:1258-62
   PubMedGoogle Scholar
• Shimamoto K, Satake H, Sawaki A, et al. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 1998;29:4-10
   PubMed Web of Science ®Google Scholar
• Bargren AE, Meyer-Rochow GY, Delbridge LW, et al. Outcomes of surgically managed pediatric thyroid cancer. J Surg Res 2009;156:70-3
   PubMedGoogle Scholar
• Handkiewicz-Junak D, Wloch J, Roskosz J, et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med 2007;48:879-88
   PubMedGoogle Scholar
• Hay ID, Gonzalez-Losada T, Reinalda MS, et al. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 2010;34:1192-202
   PubMedGoogle Scholar
• Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375-81; discussion 381-374
   PubMed Web of Science ®Google Scholar
• Sosa JA, Bowman HM, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998;228:320-30
   PubMed Web of Science ®Google Scholar
• Popadich A, Levin O, Lee JC, et al. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery 2011;150:1048-57
   PubMed Web of Science ®Google Scholar
• Giacomini CP, Jeffrey RB, Shin LK. Ultrasonographic evaluation of malignant and normal cervical lymph nodes. Semin Ultrasound CT MR 2013;34:236-47
   PubMedGoogle Scholar
• Kruijff S, Petersen JF, Chen P, et al. Patterns of structural recurrence in papillary thyroid cancer. World J Surg 2013. [Epub ahead of print]
   Google Scholar
• Barczynski M, Konturek A, Stopa M, Nowak W. Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg 2013;100:410-18
   PubMed Web of Science ®Google Scholar
• Wang LY, Versnick MA, Gill AJ, et al. Level VII is an important component of central neck dissection for papillary thyroid cancer. Ann Surg Oncol 2013;20:2261-5
   PubMedGoogle Scholar
• Choi JY, Choi YS, Park YH, Kim JH. Experience and analysis of level VII cervical lymph node metastases in patients with papillary thyroid carcinoma. J Korean Surg Soc 2011;80:307-12
   PubMedGoogle Scholar
• Ducoudray R, Tresallet C, Godiris-Petit G, et al. Prophylactic lymph node dissection in papillary thyroid carcinoma: is there a place for lateral neck dissection? World J Surg 2013;37:1584-91
   PubMedGoogle Scholar
• Dinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in children: diagnosis and management. Curr Opin Oncol 2008;20:59-65
   PubMedGoogle Scholar
• Chow SM, Law SC, Mendenhall WM, et al. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine. Pediatr Blood Cancer 2004;42:176-83
   PubMedGoogle Scholar
• Pawelczak M, David R, Franklin B, et al. Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following (1)(3)(1)I treatment: a systematic review. Thyroid 2010;20:1095-101
   PubMed Web of Science ®Google Scholar
• White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg 2007;31:895-904
   PubMed Web of Science ®Google Scholar
• Shen WT, Ogawa L, Ruan D, et al. Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg 2010;145:272-5
   PubMedGoogle Scholar
• Schmidt M, Baum RP, Simon T, Howman-Giles R. Therapeutic nuclear medicine in pediatric malignancy. Q J Nucl Med Mol Imaging 2010;54:411-28
   PubMedGoogle Scholar
• Van Nostrand D. The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer. Thyroid 2009;19:1381-91
   PubMed Web of Science ®Google Scholar
• Clayman GL, Shellenberger TD, Ginsberg LE, et al. Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 2009;31:1152-63
   PubMedGoogle Scholar
• Available from: www.awmf.org/uploads/tx_szleitlinien/031-043l_S1_Radiotherapie_I-131-Ganzk%C3%B6rperszintigraphie_Schilddr%C3%BCsenkarzinom_im_Kindes_Jugendalter_2013-07.pdf
   Google Scholar
• Durante C, Montesano T, Attard M, et al. Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement? J Clin Endocrinol Metab 2012;97:2748-53
   PubMedGoogle Scholar
• Parisi MT, Mankoff D. Differentiated pediatric thyroid cancer: correlates with adult disease, controversies in treatment. Semin Nucl Med 2007;37:340-56
   PubMedGoogle Scholar
• Yeh SD, La Quaglia MP. 131I therapy for pediatric thyroid cancer. Semin Pediatr Surg 1997;6:128-33
   PubMedGoogle Scholar
• Bomeli SR, Schaitkin B, Carrau RL, Walvekar RR. Interventional sialendoscopy for treatment of radioiodine-induced sialadenitis. Laryngoscope 2009;119:864-7
   PubMedGoogle Scholar
• Verburg FA, Biko J, Diessl S, et al. I-131 activities as high as safely administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancer. J Clin Endocrinol Metab 2011;96:E1268-71
   Google Scholar
• Bhattacharyya N, Chien W. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma. Ann Otol Rhinol Laryngol 2006;115:607-10
   PubMedGoogle Scholar
• Luster M, Handkiewicz-Junak D, Grossi A, et al. Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study. J Clin Endocrinol Metab 2009;94:3948-53
   PubMedGoogle Scholar
• Brabant G. Thyrotropin suppressive therapy in thyroid carcinoma: what are the targets? J Clin Endocrinol Metab 2008;93:1167-9
   PubMed Web of Science ®Google Scholar
• McGriff NJ, Csako G, Gourgiotis L, et al. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 2002;34:554-64
   PubMed Web of Science ®Google Scholar
• Baudin E, Do Cao C, Cailleux AF, et al. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 2003;88:1107-11
   PubMed Web of Science ®Google Scholar
• Sywak MS, Palazzo FF, Yeh M, et al. Parathyroid hormone assay predicts hypocalcaemia after total thyroidectomy. ANZ J Surg 2007;77:667-70
   PubMedGoogle Scholar
• Kalicke T, Grunwald F, Bender H, Biersack HJ. Clinical indications for the use of Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer. Clin Positron Imaging 1998;1:193-9
   PubMedGoogle Scholar
• Grunwald F, Kalicke T, Feine U, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 1999;26:1547-52
   PubMedGoogle Scholar
• Carling T, Carty SE, Ciarleglio MM, et al. American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 2012;22:237-44
   PubMedGoogle Scholar
• Schneider TC, Abdulrahman RM, Corssmit EP, et al. Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial. Eur J Endocrinol 2012;167:643-50
   PubMed Web of Science ®Google Scholar